This addition highlights our commitment to meeting market needs and providing high-quality over the-counter solutions for our customers
The robotic surgery program has continually pushed the boundaries of medical technology
In a Phase 3 trial, Pfizer and BioNTech’s combination vaccine candidate against influenza and COVID-19 met one of its two primary immunogenicity objectives
Becomes the first rehab & recovery center in east India to earn NABH accreditation
Gross profit was Rs. 328.8 crore, up by 27.8% YoY with a gross margin expansion of 418 bps to 55.7%
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
Third approval in China for AstraZeneca and Daiichi Sankyo’s Enhertu in less than two years
Revenue from operations stood at Rs. 313.4 crore during Q1 FY25
CN201 is a next generation CD3xCD19 bispecific antibody that augments and diversifies Merck’s pipeline, with potential applications in B-cell malignancies and autoimmune diseases
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
Subscribe To Our Newsletter & Stay Updated
